Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
INFECTIVE ENDOCARDITIS พญ.วันวรุณ พุ่มชุมพล INFECTIVE ENDOCARDITIS Definition : proliferation of microorganisms on the endocardial surface of heart Bacteria , chlamydiae , rickettsiae , mycoplasma , fungi and virus Vegetation : mass of plt. , fibrin , microcolonies of microorganism , scant inflammatory cell Moss common : heart valves Infective endarteritis CLASSIFICATION Acute : fulminant, high fever, rapidly damages cardiac structures, hematogenously seeds extracardiac sites, death < 6 wk : Staphylococcus aureus , Streptococcus pyogenes , Streptococcus pneumoniae , or Neisseria gonorrhoeae Subacute : indolent course, rarely causes metastatic infection, death in 6 wk-3mo Chronic : death > 3 mo INCIDENCE 1.5-6.5 / 100,000 /year Half : injection drug use Notably increased among elderly Prosthetic valve : Cumulative rate 1.5-3% at 1 yr 3-6% at 5 yrs : greatest 6 mo. ETIOLOGY Many species of bacteria and fungi Portals of entry - Oral, skin, URI : S. viridans, Staphylococci, HACEK - GI : S. bovis (ass. Polyps & colonic tumors) : G –ve (Enterobacteriacae) - GU : Enterococci - Nosocomial : intravascular catheters : S.aureus Prosthetic valve : 2mo , NI : Intraoperative contamination : Bacteremic postoperative : S.coag.-ve, S. aureus, G-ve rod, diphtheroids, fungi : >12mo. = Community-acquired native valve :>85% S.coag-ve : MRSA Transvenous pacemaker and/or implanted defibrillator : NI , within weeks, S. aureus, S.coag -ve Injection drug users - TV - S.aureus strains : MRSA - Lt side : varied etiology & abnormal valve : P.aeruginosa, Candida spp., : Bacillus, Lactobacillus, : Corynebacterium -Polymicrobial H/C negative - 5-15% - 1/3-1/2 : prior ATB - fastidious : Pyridoxal-requiring S., G-ve coccobacillary HACEK Bartonella henselae/quintana Tropheryma whipplei PATHOGENESIS Mucous membrane or other colonized tissue Valvular endothelium trauma turbulence metabolic Platelet-fibrin deposition Trauma Nonbacterial thrombotic endocarditis (NBTE) Bacteremia Complement Ab Adherence Colonization bacterial division fibrin depositon platelet aggregation extracellular proteases neutrophils protection mature vegetation PATHOLOGIC CHANGES Heart - classic vegetation : line of closure : atrial surface of atrioventricular valve : ventricular surface of semilunar valve - singer or multiple - few mm. to several cm. in size - vary in color, consistency, gross appearance - microscopic : fibrin, platelet aggregates, bacterial mass, rare PMN&RBC - destruction of underlying valve , fibrosis after healing - acute : larger, softer, friable, may suppuration, more necrosis, less healing than subacute - large : valvular stenosis - may perforation - valve ring abscesses with fistular formation - aneurysms -CHF, myocarditis, MI, pericarditis Kidney 3 processes : infarction 56% : glomerulonephritis - focal 48-88% - diffuse 17-80% : abscesses – uncommon - normal size, slightly swollen, petechiae - all case : abnormal renal architecture Mycotic aneurysms - 10-15% - acute IE - S. viridans - mechanism : direct bacterial invasion : septic embolic occlusion : immune complex deposition - bifurcation points, common-cerebral vv (MCA) - clinically silent until rupture CNS - - - Cerebral emboli MCA and its branches Cerebral infarction, arteritis, abscesses, mycotic aneurysm, ICH, SAH, encephalomalacia, cerebritis, meningitis Hemorrhagic transformation of ischemic infarctfatal Pneumococcal : purulent meningitis S. aureus : multiple microabscesses Spleen - splenic infarction 44% : silent - splenic abscess : uncommon Lung - Rt side IE : PE +- infarct, pneumia, effusion, empyema Skin - petechiae 20-40% - Osler nodes : immune complex in dermal vessels, arteriolar intimal proliferation - Janeway lesions : septic emboli : consist of bacteria, neutrophile : necrosis, subcutaneous hemorrhage Eye - Roth spots : lymphocytes surrounded by edema and hemorrhage in nerve fiber of retina CLINICAL MANIFESTATION S&S : protean, and any organ system may be involved 4 processes 1.infectious process on the valve + complication 2.septic embolization 3.constant bacteremia 4.circulating immune complex Fever : remittent, rarely exceeds 40 c Half : afebile within 3 d. of the initiation of ATB , 75% after 1 wk , 90% after 2 wk Prolonged fever : specific etiologic agents - S. aureus, G-ve bacilli, fungi, H/C –ve IE - microvascular phenomena - embolizaton of major vessels - intracardiac – peripheral complication - tissue infarction - PE - drug reaction - NI Nonspecific symptom - anorexia, N/V, wt.loss, malaise,fatigue,chill, weakness, night sweats Heart murmur ->85% -may absent : Rt sided or mural infection -classic but uncommon 5-10% : changing murmur and development of a new regurgitant murmur Heart -CHF - Pericarditis is rare : myocardial abscess - valvular stenosis/obstruction=Sx - myocarditis - MI Classic peripheral manifestation Clubbing finger 10-20% Splinter hemorrhages : proximal nail Petchiae 20-40% : local vasculitis or emboli : conjunctivae : buccal mucosa, palate : extrenities Osler nodes 10-15% : small, painful, nodular 2-15 mm, multiple Janeway lesions : embolic :Hemorrhagic, macular, painless plaques Roth spots 5% near optic disk Splenomegaly 25-60% -splenic septic emboli : may abscent S&S Musculoskeletal 44% - proximal oligo/mono arthalgia - LBP -myalgia Major embolic episodes - splenic a. emboi : LUQ pain or Lt pleural effusion - renal infarction : hematuria -retinal a. emboli : sudden loss VA -PE : Rt sided – narcotic addicts -coronary a. emboli (AV) : myocarditis, arrhythmias,MI -major vv. Emboli : femoral, brachial, popliteal, radial a. : fungus Neuro. 20-40% - embolic : Staphylococcal - mycotic aneurysms - seizure, severe headache, visual loss, CN palsy, toxic encephalopathy, psychosis Renal - renal failure : uremia - AGN IE IN DRUG ADDICTS Acute infection 2/3 no underlying heart Most : TV alone or combine 52.2% (Rt side) : AV 18.5% : MV 10.8% : AV+MV 12.5% TV : pleuritic chest pain, blood born pneumonia : sign of tricuspid insufficiency Men 4-6 : 1 women ETIOLOGY IN NARCOTIC ADDICTS S. aureus 38% less severe than nonaddicts P. aeruginosa 14.2% Candida spp. 13.8% Enterococci 8.2% S. viridans 6% S. epidermidis 1.7% G-ve aerobic baciili 1.7-15% Other bacteria 2.2% Mixed infectious 1.3% Culture negative 12.9% ETIOLOGIC AGENTS Streptococci -most common : community , hospital -common organism :S. viridans - subacute - multiple non specific symptom ->80% : underlying heart dz. -cure rate >90% (nonenterococcus) -GI: S.bovis, enterococci Staphylococci -20-30% of IE -S. aureus coag+ve 80-90% -acute IE -normal heart valve 1/3 -fulminant :MV, AV -40% death : myocardial abscess, purulent pericarditis, valve ring abscess -narcotic addicts : S. aureus – less severe -S.epidermidis : prosthetic valve IE Enterococcus -GI tract , ant. Urethra -Lancefield group D -5-18% -subacute -older men 59 yr : after GU manipulation -younger women 37 yr : after obstetric procedures -40% no underlying heart : 95% develop murmur -high mortality Gram negative bacilli -10% of IE -2/3 coexisted/followed serious G+ve infection -most case : fastidious -common :Enterobacteriaceae , Salmonela spp. -increase risk :narcotic addicts :prosthetic valve recipients :cirrhosis -40-50 yr., duration 6 wk, Lt side, poor prognosis -persistent bacteremia vs g-ve septicemia -High levels ATB activity -2/3 normal heart valve AV & MV -large vegatations & near total occlusion Pseudomonas -abused intravenous drugs -male:female = 2.5:1 -mean age 30 -major embolic phenomena & complications Unusual G-ve -N. gonorrhoeae -HACEK group :Haemophilus spp. :Actinobacillus :Cardiobacterium :Eikenella corrodens :Kingella G+ve bacilli -Corynebacterium -Listeria monocytogenes Anaerobic bacteria HACEK -Fastidious Clinical syndrome - subacute IE, large friable, freq.emboli, CHF, need for valve replace -2-3 wk : primary isolation -subculturing : all culture-negative Haemophilus spp. -H. paraphrophilus, H. parainfluenzae, H. aphrophilus, H. seguis, H. aegyptius -0.8-1.3% -subacute, vulvulae dz. Actinobacillus actinomycetemcomitans -rare, subacute, mortality 34% Cardiobacterium hominis - resembles Haemophilus Eikenella corrodens -IVDU -usual habitant of oropharynx -indolent Kingella endocarditis -50% : complication eg. stroke FUNGI 3 pt group -narcotic addicts -reconstructive cardiovascular suegery -prolonged intravenous ATB Underlying heart : 2/3 major systemic emboli Addicts : C. parapsilosis : C. tropicalis Non addicts : C. albicans : Aspergillus spp. Acute -B-hemolytic streptococci -S. aureus (occasional:subacute) -Pneumococci Subacute -S. viridans -Enterococci (may acute) -S. coag –ve (may acute) -HACEK group LAB Echocardiography - identified vegetations : confirm IE : intracardiac complication : size : cardiac function - sensitivity & specificity : uncertain : TTE sens. 65% - Rt side, not seen <2mm : TEE sens. >90% - prosthetic, intracardiac complication - vegetation > 1 cm : stroke DIAGNOSIS Clinical definite diagnosis -2 major -1 major + 3 minor -5 minor Possible -1 major + 1 minor -3 minor Reject -resolve/not recur <=4 d.ATB -no histologic of endocarditis TREATMENT INDICATION Empirically immediately ATB : take H/C 3 spp. - acute IE - deterioration hemodynamics - may require urgent surgery Acute + IVDU : Vancomycin + Gentemicin Subacute Prosthertic : Ceftriazone + Gentamicin :+Vancomicin IE PROPHYLAXIS Single dose before procedure Dental procedure -S. viridans Respiratory tract procedure -S. viridans -S. aureus Skin & musculoskeletal -Staphylococci -B-hemolytic streptococci GI & GU procedure : not prophylaxis -Enterococci SUMMARY 1. Bacteremia from daily activity > procedure 2. prevent : small number of case 3. limit in table 3 4. dental, RS, skin, musculoskelatal procedure in underlying cardiac condition 5. not recommen in GI & GU